Cell Fate Engineering Tools for iPSC Disease Modeling.

The field of cell fate engineering is contingent on tools that can quantitatively assess the efficacy of cell fate engineering protocols and experiments. CellNet is such a cell fate assessment tool that utilizes network biology to both evaluate and suggest candidate transcriptional regulatory modifications to improve the similarity of an engineered population to its corresponding in vivo target population. CellNet takes in expression profiles in the form of RNA-sequencing data and generates several metrics of cell identity and protocol efficacy. In this chapter, we demonstrate how to (1) preprocess raw RNA-sequencing data to generate an expression matrix, (2) train CellNet using preprocessed expression matrices, and (3) apply CellNet to a query study and interpret its results. We demonstrate the utility of CellNet for analysis of iPSC disease modeling studies, which we evaluate through the lens of cell fate engineering.

[1]  Patrick Cahan.  Enabling direct fate conversion with network biology , 2016, Nature Genetics.

[2]  Ilya Shmulevich,et al.  Gene pair signatures in cell type transcriptomes reveal lineage control , 2013, Nature Methods.

[3]  Jeesoo Kim,et al.  Assessment of engineered cells using CellNet and RNA-seq , 2017, Nature Protocols.

[4]  Stormy J. Chamberlain,et al.  Gene expression analysis of human induced pluripotent stem cell-derived neurons carrying copy number variants of chromosome 15q11-q13.1 , 2014, Molecular Autism.

[5]  D. Krainc,et al.  Human iPSC-based modeling of late-onset disease via progerin-induced aging. , 2013, Cell stem cell.

[6]  J. Goeman,et al.  KeyGenes, a Tool to Probe Tissue Differentiation Using a Human Fetal Transcriptional Atlas , 2015, Stem cell reports.

[7]  N. Benvenisty,et al.  TeratoScore: Assessing the Differentiation Potential of Human Pluripotent Stem Cells by Quantitative Expression Analysis of Teratomas , 2015, Stem cell reports.

[8]  Michael P Snyder,et al.  iPSC-derived cardiomyocytes reveal abnormal TGFβ signaling in left ventricular non-compaction cardiomyopathy , 2016, Nature Cell Biology.

[9]  S. Eddy,et al.  Transcription Factors That Convert Adult Cell Identity Are Differentially Polycomb Repressed , 2013, PloS one.

[10]  Stylianos E. Antonarakis,et al.  Domains of genome-wide gene expression dysregulation in Down’s syndrome , 2014, Nature.

[11]  S. Mooney,et al.  Genomic Analysis Reveals Disruption of Striatal Neuronal Development and Therapeutic Targets in Human Huntington’s Disease Neural Stem Cells , 2015, Stem cell reports.

[12]  D. J. Driscoll,et al.  Induced pluripotent stem cells (iPSC) created from skin fibroblasts of patients with Prader-Willi syndrome (PWS) retain the molecular signature of PWS. , 2016, Stem cell research.

[13]  Patrick Cahan,et al.  Computational Tools for Stem Cell Biology. , 2016, Trends in biotechnology.

[14]  A. VanDongen,et al.  Genetic Correction of SOD1 Mutant iPSCs Reveals ERK and JNK Activated AP1 as a Driver of Neurodegeneration in Amyotrophic Lateral Sclerosis , 2017, Stem cell reports.

[15]  A. del Sol,et al.  A general strategy for cellular reprogramming: The importance of transcription factor cross‐repression , 2013, Stem cells.

[16]  Beth L. Pruitt,et al.  Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis , 2016, Cell.

[17]  Amanda J. Kedaigle,et al.  Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice , 2017, Nature Neuroscience.

[18]  G. Pruneri,et al.  7q11.23 dosage-dependent dysregulation in human pluripotent stem cells affects transcriptional programs in disease-relevant lineages , 2014, Nature Genetics.

[19]  Bernhard M. Schuldt,et al.  A bioinformatic assay for pluripotency in human cells , 2011, Nature Methods.

[20]  D. Geschwind,et al.  Altered proliferation and networks in neural cells derived from idiopathic autistic individuals , 2016, Molecular Psychiatry.

[21]  J. Casanova,et al.  Capturing the biology of disease severity in a PSC-based model of familial dysautonomia , 2016, Nature Medicine.

[22]  Sally Temple,et al.  A Systematic Approach to Identify Candidate Transcription Factors that Control Cell Identity , 2015, Stem cell reports.

[23]  S. Antonarakis,et al.  Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 , 2013, EMBO molecular medicine.

[24]  James J. Collins,et al.  Epigenetic Landscapes Explain Partially Reprogrammed Cells and Identify Key Reprogramming Genes , 2012, PLoS Comput. Biol..

[25]  J. Nurnberger,et al.  Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder , 2015, Nature.

[26]  David G Hendrickson,et al.  Genome-wide RNA-Seq of Human Motor Neurons Implicates Selective ER Stress Activation in Spinal Muscular Atrophy. , 2015, Cell stem cell.

[27]  D. Melton,et al.  An improved ScoreCard to assess the differentiation potential of human pluripotent stem cells , 2015, Nature Biotechnology.

[28]  David W. Nauen,et al.  Synaptic dysregulation in a human iPS cell model of mental disorders , 2014, Nature.

[29]  Peter Reinhardt,et al.  Investigating human disease using stem cell models , 2014, Nature Reviews Genetics.

[30]  J. Rapoport,et al.  Dysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Derived Neural Progenitor Cells. , 2016, Cell reports.

[31]  Guoping Fan,et al.  Integrated transcriptome analysis of human iPS cells derived from a fragile X syndrome patient during neuronal differentiation , 2016, Science China Life Sciences.

[32]  Samantha A. Morris,et al.  CellNet: Network Biology Applied to Stem Cell Engineering , 2014, Cell.

[33]  Fabian Grubert,et al.  Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers. , 2017, Cell stem cell.

[34]  L. Petrucelli,et al.  Dhruv Sareen Repeat Expansion C 9 ORF 72 with a Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients , 2013 .

[35]  A. del Sol,et al.  Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs , 2014, Nature Communications.

[36]  Kinyui A. Lo,et al.  Differentiation of hypothalamic-like neurons from human pluripotent stem cells. , 2015, The Journal of clinical investigation.

[37]  J. Takahashi,et al.  Modeling the Early Phenotype at the Neuromuscular Junction of Spinal Muscular Atrophy Using Patient-Derived iPSCs , 2015, Stem cell reports.

[38]  Yoshihide Hayashizaki,et al.  A predictive computational framework for direct reprogramming between human cell types , 2016, Nature Genetics.